RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+7.6%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$696M
AUM Growth
+$696M
(+10%)
Cap. Flow
+$38.2M
Cap. Flow
% of AUM
5.48%
Top 10 Holdings %
Top 10 Hldgs %
28.66%
Holding
112
New
8
Increased
33
Reduced
36
Closed
4
Top Buys
| 1 |
NovoCure
NVCR
|
$21M |
| 2 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$13.8M |
| 3 |
Exelixis
EXEL
|
$10.3M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$7.96M |
| 5 |
Sanofi
SNY
|
$7.67M |
Top Sells
| 1 |
Amgen
AMGN
|
$11.2M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$10.8M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$8.62M |
| 4 |
Esperion Therapeutics
ESPR
|
$8.33M |
| 5 |
Biogen
BIIB
|
$5.29M |
Sector Composition
| 1 | Healthcare | 92.59% |
| 2 | Financials | 0.93% |
| 3 | Technology | 0.13% |
| 4 | Energy | 0.1% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
AB InBev
BUD
$116B
| $310K | 0.04% |
2,806
| – | – |
|
102
Qualcomm
QCOM
$170B
| $296K | 0.04% |
5,368
| – | – |
|
103
IBM
IBM
$227B
| $272K | 0.04% |
1,847
| – | – |
|
104
Tandem Diabetes Care
TNDM
$834M
| $187K | 0.03% |
23,400
| – | – |
|
|
MRTX
105
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $183K | 0.03% |
50,000
| – | – |
|
|
MTEM
106
DELISTED
Molecular Templates, Inc.
MTEM
| $79K | 0.01% |
1,221
| – | – |
|
|
ISEE
107
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $61K | 0.01% |
23,920
| – | – |
|
|
ANTH
108
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $41K | 0.01% |
25,000
| – | – |
|
109
Becton Dickinson
BDX
$54.3B
| – | – |
-5,125
| Closed | -$917K |
|
110
Intuitive Surgical
ISRG
$158B
| – | – |
-36,000
| Closed | -$3.07M |
|
111
Viatris
VTRS
$12.3B
| – | – |
-90,000
| Closed | -$3.51M |
|
|
TSRO
112
DELISTED
TESARO, Inc.
TSRO
| – | – |
-5,000
| Closed | -$769K |
|